MHR
GSK icon

Matthew Hamilton Rosenberg’s GSK GSK Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Buy
2,326
+950
+69% +$50.2K 0.02% 320
2026
Q1 		$75.9K Hold
1,376
– – 0.02% 368
2025
Q4 		$67.5K Hold
1,376
– – 0.01% 385
2025
Q3 		$59.4K Hold
1,376
– – 0.01% 398
2025
Q2 		$52.8K Sell
1,376
-189
-12% -$7.22K 0.01% 427
2025
Q1 		$60.6K Sell
1,565
-236
-13% -$8.64K 0.02% 391
2024
Q4 		$60.9K Sell
1,801
-849
-32% -$30.6K 0.02% 390
2024
Q3 		$108K Buy
2,650
+164
+7% +$6.71K 0.03% 309
2024
Q2 		$95.4K Sell
2,486
-164
-6% -$6.9K 0.03% 306
2024
Q1 		$112K Sell
2,650
-4
-0.2% -$165 0.03% 291
2023
Q4 		$98.3K Hold
2,654
– – 0.03% 310
2023
Q3 		$96.2K Hold
2,654
– – 0.03% 289
2023
Q2 		$94.6K Buy
2,654
+212
+9% +$7.6K 0.03% 308
2023
Q1 		$86.9K Sell
2,442
-246
-9% -$8.61K 0.03% 343
2022
Q4 		$94.5K Buy
2,688
+163
+6% +$5.43K 0.03% 317
2022
Q3 		$74K Buy
2,525
+1,401
+125% +$53.1K 0.03% 349
2022
Q2 		$61K Hold
1,124
– – 0.02% 405
2022
Q1 		$61K Hold
1,124
– – 0.02% 412
2021
Q4 		$62K Buy
1,124
+640
+132% +$33.3K 0.02% 381
2021
Q3 		$23K Hold
484
– – 0.01% 494
2021
Q2 		$24K Hold
484
– – 0.01% 456
2021
Q1 		$22K Hold
484
– – 0.01% 435
2020
Q4 		$22K Sell
484
-1,141
-70% -$52.4K 0.01% 417
2020
Q3 		$76K Hold
1,625
– – 0.06% 243
2020
Q2 		$83K Buy
1,625
+98
+6% +$5.03K 0.07% 229
2020
Q1 		$73K Buy
+1,527
New +$81.5K 0.07% 189

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Matthew Hamilton Rosenberg's GSK Position: Q2 2026 in Review

Matthew Hamilton Rosenberg increased its GSK (GSK) stake by 69% in Q2 2026, buying an estimated $50.2K and bringing the position to 2,326 shares worth $122K. The position accounts for 0.02% of the portfolio, ranked #320.

Matthew Hamilton Rosenberg first reported a position in GSK in Q1 2020 and has held it in 26 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Matthew Hamilton Rosenberg held 2,326 shares of GSK worth $122K as of Q2 2026.
  • Matthew Hamilton Rosenberg bought 950 GSK shares in Q2 2026, an estimated $50.2K.
  • GSK made up 0.02% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #320 holding.
  • Matthew Hamilton Rosenberg first reported a position in GSK in Q1 2020 and has held it in 26 quarters since.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.